Sarepta Therapeutics Inc.
SRPT:NASDAQ
Sarepta Therapeutics is a biopharmaceutical company developing RNA-targeted therapeutics that addres serious and life-threatening diseases including Duchenne muscular dystrophy and infectious diseases such as influenza, and the Ebola virus.
Streetwise Company Fact Sheet2026/3/27 15:42:44
(SRPT:NASDAQ)
Analyst coverage
| H.C. Wainwright & Co. — Mitchell Kapoor |
| Wedbush — Dr. Yun Zhong |
Streetwise Reports Articles
| 03/27/2026 - View Article |
| 03/27/2026 - View Article |
| 03/26/2026 - View Article |
Streetwise - Sarepta Therapeutics Inc. Ownership Overview*
Sarepta Therapeutics Inc. (SRPT:NASDAQ)
*Share Structure as of 3/27/2026
© 2026 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
